BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6679687)

  • 1. Erythrocyte deformability in patients with arteriosclerosis obliterans of lower limbs.
    Lukjan H; Rość D; Chyzy R; Szpak A
    Acta Med Pol; 1983; 24(1-4):55-63. PubMed ID: 6679687
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs.
    Lukjan H; Rość D; Chyzy R; Bodzenta A; Szpak A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):191-6. PubMed ID: 2581865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood coagulation in arteriosclerosis obliterans of the lower limbs].
    Chubar' SV
    Vrach Delo; 1978 Oct; (10):21-5. PubMed ID: 716352
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the clotting system and fibrinolysis after 1-stage novocaine parasciatic blockade in patients with obliterating atherosclerosis of the lower limbs].
    Kempf Z
    Przegl Lek; 1970 Sep; 26(9):735-7. PubMed ID: 5472570
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum zinc and copper in patients with atherosclerosis obliterans of the lower limbs].
    Uza C; Kovacs A; Vlaicu R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(6):509-13. PubMed ID: 6136075
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
    Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
    Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lipid metabolism indices of patients with arteriosclerosis obliterans of the lower extremities].
    Satmari VV; Kucher VN; Portugal' AS; Gribenko VV
    Vrach Delo; 1984 Feb; (2):70-1. PubMed ID: 6719877
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of patients with arteriosclerosis obliterans of the lower limbs].
    Malec E
    Pol Przegl Chir; 1980 Jan; 52(1):41-5. PubMed ID: 7383938
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood basocytes in obliterative arteriosclerosis of lower limbs].
    Gonciarz Z
    Pol Tyg Lek; 1967 Sep; 22(39):1480-2. PubMed ID: 6082508
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of various blood coagulation and hemorrheological parameters in arteriosclerotic vascular disease of the lower legs].
    Avellone G; Mandalà V; Novo S; Pinto A; Davì G; Raneli G; Strano A
    Ric Clin Lab; 1983; 13 Suppl 3():297-301. PubMed ID: 6200915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythrocyte aggregation, erythrocyte filterability and membrane fluidity in single-area atherosclerotic vascular disease].
    Sarno A; Serra A; Catania A; Francavilla G; Lo Presti R; Caimi G
    Ric Clin Lab; 1989; 19 Suppl 1():133-6. PubMed ID: 2629073
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior and significance of beta-thromboglobulin in chronic obliterating arteriopathy of the lower limbs. Preliminary research].
    Binaghi F; Valle E; Manconi E; Pitzus F
    Cardiologia; 1982 Nov; 27(11):1043-9. PubMed ID: 6085827
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rheologic aspects of the hematocrit and fibrinogen in evaluating rheographic measurements in patients with arteriosclerosis of the lower extremities].
    Dabrowski S; Lukjan H; Bielawiec M; Giedrojć J
    Kardiol Pol; 1986; 29(8):551-4. PubMed ID: 3560597
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical importance of the regional study of blood serum lipids in arteriosclerosis obliterans of the arteries of the lower extremities].
    Ovchinnikov VA; Kontorshchikova KN; Parakhoniak NV
    Patol Fiziol Eksp Ter; 1986; (2):23-5. PubMed ID: 3714313
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
    Berent H; Kancelarczyk WL; Zebrowski M; Uchman B
    Pol Tyg Lek; 1988 Jun; 43(24):776-8. PubMed ID: 3237518
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of suloctidil therapy on platelet function in patients with on obliterating arteriopathy of the lower limbs].
    Davì G; Pinto A; Novo S; Avellone G; Galati D; Mazzola A
    Clin Ter; 1982 Oct; 103(2):131-7. PubMed ID: 6295693
    [No Abstract]   [Full Text] [Related]  

  • 17. [A method of correction of hemorheological disorders in patients with thrombobliterating diseases of the peripheral arteries of the limbs].
    Litmanovich KIu; Mel'nikova VN; Fregatova LM; Kargin VD; Egorova LV
    Vestn Khir Im I I Grek; 1985 Jul; 135(7):96-9. PubMed ID: 4060495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Platelet aggregation in obliterating arteriopathies of the lower limbs. Preliminary findings].
    Rossi M; Evangelisti L; Giusti C; Santoro G; Pentimone F; Camici M
    Minerva Cardioangiol; 1982 Jun; 30(6):329-33. PubMed ID: 7133421
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the platelet component in chronic obliterating vascular disease of the lower limbs].
    Avellone G; Nova S; Gullotti D; Mandalà V
    Boll Soc Ital Cardiol; 1979; 24(2):135-41. PubMed ID: 548089
    [No Abstract]   [Full Text] [Related]  

  • 20. [The lipid composition of the blood plasma in patients with ischemic heart disease and concomitant arteriosclerosis obliterans of the arteries of the lower extremities].
    Iastrebov GN; Volkov VS; Bel'chenko DI
    Ter Arkh; 1992; 64(9):61-4. PubMed ID: 1481157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.